MT-6194

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMT-6194

Drug Alias NameFynomAbs (Covagen/Mitsubishi Tanabe Pharma)Bispecific IL-6R/IL-17A antibody (Mitsubishi Tanabe)Bispecific proteins (Covagen/Mitsubishi Tanabe Pharma)MT-6194

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionInterleukin 17A inhibitorsIL-6 receptor antagonists

TargetsInterleukin 17AIL-6 receptor

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMitsubishi Tanabe Pharma Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMitsubishi Tanabe Pharma Corp

Active IndicationsN/A

Inactive IndicationsInflammation

Other Information

ATC CodeN/A